CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- Open-market buys, last 90 days
- $252,875
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-25 | Jarrett Jennifer Director, President and CEO | Purchase | +12,500 | $20.23 | $253K | 512,500 |
| 2026-08-12 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +30,350 | 30,350 | ||
| 2026-07-06 | Winslow Garrett General Counsel | Sale | −245 | $29.98 | $7K | 2,289 |
| 2026-07-03 | Winslow Garrett General Counsel | Option exercise | +680 | 2,534 | ||
| 2026-07-03 | Winslow Garrett General Counsel | Option exercise · Restricted Stock Units | −680 | 640 | ||
| 2026-03-30 | Jarrett Jennifer See Remarks | Grant or award | +500,000 | 500,000 | ||
| 2026-03-30 | Jarrett Jennifer See Remarks | Grant or award · Stock Option (right to buy) | +1,500,000 | 1,500,000 | ||
| 2026-03-23 | Winslow Garrett General Counsel | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2026-03-23 | Turtle Cameron Director | Grant or award · Stock Option (right to buy) | +37,313 | 37,313 | ||
| 2026-03-23 | Landsittel Michael Director | Grant or award · Stock Option (right to buy) | +37,313 | 37,313 | ||
| 2026-03-23 | Fairmount Funds Management LLC Director | Grant or award · Stock Option (right to buy) | +37,313 | 37,313 | ||
| 2026-03-23 | CAIN CHRISTOPHER W. Director | Grant or award · Stock Option (right to buy) | +37,313 | 37,313 | ||
| 2026-03-23 | Bruno Julianne Director | Grant or award · Stock Option (right to buy) | +37,313 | 37,313 | ||
| 2026-02-09 | Bruno Julianne Director | Option exercise | +129,000 | 137,032 | ||
| 2026-02-09 | Bruno Julianne Director | Option exercise · Series C Preferred Stock | −129 | 0 | ||
| 2026-02-09 | Fairmount Funds Management LLC Director | Option exercise | +5,809,000 | 5,809,000 | ||
| 2026-02-09 | Fairmount Funds Management LLC Director | Option exercise | +2,904,000 | 2,904,000 | ||
| 2026-02-09 | Fairmount Funds Management LLC Director | Option exercise · Series C Preferred Stock | −5,809 | 1,148 | ||
| 2026-02-09 | Fairmount Funds Management LLC Director | Option exercise · Series C Preferred Stock | −2,904 | 574 | ||
| 2026-01-05 | Sattarzadeh Sherwin Chief Operating Officer | Grant or award | +190,376 | 190,376 |
Page 1 of 12 · 227 trades